NTCOC
TRIB

Northern Trust Company of Connecticut’s Trinity Biotech TRIB Stock Holding History

Northern Trust Company of Connecticut’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$3.02M Buy
801
+320
+67% +$1.15M 0.02% 891
2013
Q3 		$1.57M Buy
+481
New +$1.41M 0.01% 1162

Other funds holding TRIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Northern Trust Company of Connecticut's TRIB Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its Trinity Biotech (TRIB) stake by 67% in Q4 2013, buying an estimated $1.15M and bringing the position to 801 shares worth $3.02M. The position accounts for 0.02% of the portfolio, ranked #891.

Northern Trust Company of Connecticut first reported a position in TRIB in Q3 2013 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold TRIB as of Q4 2013.

  • Northern Trust Company of Connecticut held 801 shares of Trinity Biotech worth $3.02M as of Q4 2013.
  • Northern Trust Company of Connecticut bought 320 Trinity Biotech shares in Q4 2013, an estimated $1.15M.
  • Trinity Biotech made up 0.02% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #891 holding.
  • Northern Trust Company of Connecticut first reported a position in Trinity Biotech in Q3 2013 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.